Making the most of uncertainty

Treasuring exceptions in prenatal diagnosis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Throughout the 20th century, human genetics research was driven by the identification of new variants. As pioneering geneticist William Bateson put it, novel variants were "exceptions" to "treasure". With the rise of human chromosomal analysis in the postwar period, the identification of genetic variants became increasingly significant to clinical and prenatal diagnosis. Human geneticists had long sought a broader sampling of human genetic variation, from a largely "normal" population. The expansion of prenatal diagnosis in the late 20th century offered a new resource for identifying novel genetic variants. In the prenatal diagnostic setting however, many of the exceptions to be treasured were of uncertain clinical significance, which raised anxiety among parents. In the early 1990s, providers reported that specific uncertain results from chorionic villus sampling (CVS) facilitated prenatal diagnoses that were not previously possible. Based on this, some prenatal diagnostic providers began to embrace uncertainty, when properly managed to reduce anxiety, rather than prevent it. The potential to produce uncertainty in prenatal diagnosis grew with whole genome microarray in the 2000s. Rather than outcomes to avoid, or accept as inevitable, providers presented uncertain results as starting points for research to improve the scope prenatal diagnosis, and bring future certainty.

Fingerprint

Prenatal Diagnosis
Uncertainty
Medical Genetics
Anxiety
Chorionic Villi Sampling
Genetic Research
Genome
Research
Population
Diagnostics
Sampling

All Science Journal Classification (ASJC) codes

  • History and Philosophy of Science
  • History
  • Medicine(all)

Cite this

@article{e786edcd392f43f4948eb5b1764e0090,
title = "Making the most of uncertainty: Treasuring exceptions in prenatal diagnosis",
abstract = "Throughout the 20th century, human genetics research was driven by the identification of new variants. As pioneering geneticist William Bateson put it, novel variants were {"}exceptions{"} to {"}treasure{"}. With the rise of human chromosomal analysis in the postwar period, the identification of genetic variants became increasingly significant to clinical and prenatal diagnosis. Human geneticists had long sought a broader sampling of human genetic variation, from a largely {"}normal{"} population. The expansion of prenatal diagnosis in the late 20th century offered a new resource for identifying novel genetic variants. In the prenatal diagnostic setting however, many of the exceptions to be treasured were of uncertain clinical significance, which raised anxiety among parents. In the early 1990s, providers reported that specific uncertain results from chorionic villus sampling (CVS) facilitated prenatal diagnoses that were not previously possible. Based on this, some prenatal diagnostic providers began to embrace uncertainty, when properly managed to reduce anxiety, rather than prevent it. The potential to produce uncertainty in prenatal diagnosis grew with whole genome microarray in the 2000s. Rather than outcomes to avoid, or accept as inevitable, providers presented uncertain results as starting points for research to improve the scope prenatal diagnosis, and bring future certainty.",
author = "Hogan, {Andrew J.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.shpsc.2016.02.020",
language = "English",
volume = "57",
pages = "24--33",
journal = "Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences",
issn = "1369-8486",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Making the most of uncertainty

T2 - Treasuring exceptions in prenatal diagnosis

AU - Hogan, Andrew J.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Throughout the 20th century, human genetics research was driven by the identification of new variants. As pioneering geneticist William Bateson put it, novel variants were "exceptions" to "treasure". With the rise of human chromosomal analysis in the postwar period, the identification of genetic variants became increasingly significant to clinical and prenatal diagnosis. Human geneticists had long sought a broader sampling of human genetic variation, from a largely "normal" population. The expansion of prenatal diagnosis in the late 20th century offered a new resource for identifying novel genetic variants. In the prenatal diagnostic setting however, many of the exceptions to be treasured were of uncertain clinical significance, which raised anxiety among parents. In the early 1990s, providers reported that specific uncertain results from chorionic villus sampling (CVS) facilitated prenatal diagnoses that were not previously possible. Based on this, some prenatal diagnostic providers began to embrace uncertainty, when properly managed to reduce anxiety, rather than prevent it. The potential to produce uncertainty in prenatal diagnosis grew with whole genome microarray in the 2000s. Rather than outcomes to avoid, or accept as inevitable, providers presented uncertain results as starting points for research to improve the scope prenatal diagnosis, and bring future certainty.

AB - Throughout the 20th century, human genetics research was driven by the identification of new variants. As pioneering geneticist William Bateson put it, novel variants were "exceptions" to "treasure". With the rise of human chromosomal analysis in the postwar period, the identification of genetic variants became increasingly significant to clinical and prenatal diagnosis. Human geneticists had long sought a broader sampling of human genetic variation, from a largely "normal" population. The expansion of prenatal diagnosis in the late 20th century offered a new resource for identifying novel genetic variants. In the prenatal diagnostic setting however, many of the exceptions to be treasured were of uncertain clinical significance, which raised anxiety among parents. In the early 1990s, providers reported that specific uncertain results from chorionic villus sampling (CVS) facilitated prenatal diagnoses that were not previously possible. Based on this, some prenatal diagnostic providers began to embrace uncertainty, when properly managed to reduce anxiety, rather than prevent it. The potential to produce uncertainty in prenatal diagnosis grew with whole genome microarray in the 2000s. Rather than outcomes to avoid, or accept as inevitable, providers presented uncertain results as starting points for research to improve the scope prenatal diagnosis, and bring future certainty.

UR - http://www.scopus.com/inward/record.url?scp=84961205228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961205228&partnerID=8YFLogxK

U2 - 10.1016/j.shpsc.2016.02.020

DO - 10.1016/j.shpsc.2016.02.020

M3 - Article

VL - 57

SP - 24

EP - 33

JO - Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

JF - Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

SN - 1369-8486

ER -